Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Cobalt protoporphyrin IX increases endogenous G-CSF and mobilizes HSC and granulocytes to the blood

A. Szade, K. Szade, WN. Nowak, K. Bukowska-Strakova, L. Muchova, M. Gońka, M. Żukowska, M. Cieśla, N. Kachamakova-Trojanowska, M. Rams-Baron, A. Ratuszna, J. Dulak, A. Józkowicz,

. 2019 ; 11 (12) : e09571. [pub] 20191111

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023379

Grantová podpora
01.02.00-069/09 European Union - International
NCN2015/18/M/NZ3/00387 National Science Center - International
NCN2013/11/N/NZ3/00956 National Science Center - International
1319/MOB/IV/2015/0 Ministry of Science and Higher Education, Republic of Poland - International
1273/MOB/IV/2015/0 Ministry of Science and Higher Education, Republic of Poland - International

Granulocyte colony-stimulating factor (G-CSF) is used in clinical practice to mobilize cells from the bone marrow to the blood; however, it is not always effective. We show that cobalt protoporphyrin IX (CoPP) increases plasma concentrations of G-CSF, IL-6, and MCP-1 in mice, triggering the mobilization of granulocytes and hematopoietic stem and progenitor cells (HSPC). Compared with recombinant G-CSF, CoPP mobilizes higher number of HSPC and mature granulocytes. In contrast to G-CSF, CoPP does not increase the number of circulating T cells. Transplantation of CoPP-mobilized peripheral blood mononuclear cells (PBMC) results in higher chimerism and faster hematopoietic reconstitution than transplantation of PBMC mobilized by G-CSF. Although CoPP is used to activate Nrf2/HO-1 axis, the observed effects are Nrf2/HO-1 independent. Concluding, CoPP increases expression of mobilization-related cytokines and has superior mobilizing efficiency compared with recombinant G-CSF. This observation could lead to the development of new strategies for the treatment of neutropenia and HSPC transplantation.

000      
00000naa a2200000 a 4500
001      
bmc20023379
003      
CZ-PrNML
005      
20201214125903.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.15252/emmm.201809571 $2 doi
035    __
$a (PubMed)31709729
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Szade, Agata $u Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
245    10
$a Cobalt protoporphyrin IX increases endogenous G-CSF and mobilizes HSC and granulocytes to the blood / $c A. Szade, K. Szade, WN. Nowak, K. Bukowska-Strakova, L. Muchova, M. Gońka, M. Żukowska, M. Cieśla, N. Kachamakova-Trojanowska, M. Rams-Baron, A. Ratuszna, J. Dulak, A. Józkowicz,
520    9_
$a Granulocyte colony-stimulating factor (G-CSF) is used in clinical practice to mobilize cells from the bone marrow to the blood; however, it is not always effective. We show that cobalt protoporphyrin IX (CoPP) increases plasma concentrations of G-CSF, IL-6, and MCP-1 in mice, triggering the mobilization of granulocytes and hematopoietic stem and progenitor cells (HSPC). Compared with recombinant G-CSF, CoPP mobilizes higher number of HSPC and mature granulocytes. In contrast to G-CSF, CoPP does not increase the number of circulating T cells. Transplantation of CoPP-mobilized peripheral blood mononuclear cells (PBMC) results in higher chimerism and faster hematopoietic reconstitution than transplantation of PBMC mobilized by G-CSF. Although CoPP is used to activate Nrf2/HO-1 axis, the observed effects are Nrf2/HO-1 independent. Concluding, CoPP increases expression of mobilization-related cytokines and has superior mobilizing efficiency compared with recombinant G-CSF. This observation could lead to the development of new strategies for the treatment of neutropenia and HSPC transplantation.
650    _2
$a zvířata $7 D000818
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a faktor stimulující kolonie granulocytů $x metabolismus $7 D016179
650    _2
$a granulocyty $x účinky léků $7 D006098
650    _2
$a mobilizace hematopoetických kmenových buněk $7 D019650
650    _2
$a hematopoetické kmenové buňky $x účinky léků $7 D006412
650    _2
$a hemoxygenasa-1 $x nedostatek $x genetika $7 D051547
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a myši knockoutované $7 D018345
650    _2
$a protoporfyriny $x farmakologie $7 D011524
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Szade, Krzysztof $u Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
700    1_
$a Nowak, Witold N $u Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
700    1_
$a Bukowska-Strakova, Karolina $u Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland. Department of Clinical Immunology and Transplantology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
700    1_
$a Muchova, Lucie $u Fourth Department of Internal Medicine and Institute of Medical Biochemistry and Laboratory Medicine, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Gońka, Monika $u Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
700    1_
$a Żukowska, Monika $u Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
700    1_
$a Cieśla, Maciej $u Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
700    1_
$a Kachamakova-Trojanowska, Neli $u Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland. Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
700    1_
$a Rams-Baron, Marzena $u A. Chelkowski Institute of Physics, University of Silesia, Chorzow, Poland. Silesian Center for Education and Interdisciplinary Research, Chorzow, Poland.
700    1_
$a Ratuszna, Alicja $u A. Chelkowski Institute of Physics, University of Silesia, Chorzow, Poland. Silesian Center for Education and Interdisciplinary Research, Chorzow, Poland.
700    1_
$a Dulak, Józef $u Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland. Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
700    1_
$a Józkowicz, Alicja $u Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
773    0_
$w MED00189522 $t EMBO molecular medicine $x 1757-4684 $g Roč. 11, č. 12 (2019), s. e09571
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31709729 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214125902 $b ABA008
999    __
$a ok $b bmc $g 1595698 $s 1114055
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 11 $c 12 $d e09571 $e 20191111 $i 1757-4684 $m EMBO molecular medicine $n EMBO Mol Med $x MED00189522
GRA    __
$a 01.02.00-069/09 $p European Union $2 International
GRA    __
$a NCN2015/18/M/NZ3/00387 $p National Science Center $2 International
GRA    __
$a NCN2013/11/N/NZ3/00956 $p National Science Center $2 International
GRA    __
$a 1319/MOB/IV/2015/0 $p Ministry of Science and Higher Education, Republic of Poland $2 International
GRA    __
$a 1273/MOB/IV/2015/0 $p Ministry of Science and Higher Education, Republic of Poland $2 International
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...